1. Epigenetic Mechanisms in Canine Cancer
   Pedro Luiz Porfirio Xavier et al, 2020, Frontiers in Oncology CrossRef
2. Structure basis for AA98 inhibition on the activation of endothelial cells mediated by CD146
   Xuehui Chen et al, 2021, iScience CrossRef
3. Understanding the Mechanisms by Which Epigenetic Modifiers Avert Therapy Resistance in Cancer
   Anthony Quagliano et al, 2020, Frontiers in Oncology CrossRef
4. Histone modifications: A review about the presence of this epigenetic phenomenon in carcinogenesis
   Emanuely Silva Chrun et al, 2017, Pathology - Research and Practice CrossRef
5. Evaluation of the diagnostic utility of MCAM-1 (CD146) in a group of common gynecological cancers: A case-control study
   Amit Kumar et al, 2024, Journal of Turkish Society of Obstetric and Gynecology CrossRef
6. Transcriptional factor Yin Yang 1 facilitates the stemness of ovarian cancer via suppressing miR-99a activity through enhancing its deacetylation level
   Sumin Qian et al, 2020, Biomedicine & Pharmacotherapy CrossRef
7. Ovarian cancer: epigenetics, drug resistance, and progression
   Weiwei Xie et al, 2021, Cancer Cell International CrossRef
8. CD146, from a melanoma cell adhesion molecule to a signaling receptor
   Zhaoqing Wang et al, 2020, Signal Transduction and Targeted Therapy CrossRef
9. MicroRNA-132 modifies angiogenesis in patients with ischemic cerebrovascular disease by suppressing the NF‑κB and VEGF pathway
   Fengli Che et al, 2017, Molecular Medicine Reports CrossRef
10. Stratification of ovarian cancer patients from the prospect of drug target-related transcription factor protein activity: the prognostic and genomic landscape analyses
    Dongqing Su et al, 2023, Briefings in Functional Genomics CrossRef
11. Drug repurposing analysis with co-expressed genes identifies novel drugs and small molecules for bladder cancer
    Esra Göv et al, 2024, Journal of Scientific Reports-A CrossRef
12. CD146, a therapeutic target involved in cell plasticity
    Zhenzhen Wu et al, 2024, Science China Life Sciences CrossRef
13. Identification of Potential Biomarkers in Association With Progression and Prognosis in Epithelial Ovarian Cancer by Integrated Bioinformatics Analysis
    Jinhui Liu et al, 2019, Frontiers in Genetics CrossRef
14. MicroRNA-Mediated Drug Repurposing Unveiled Potential Candidate Drugs for Prolactinoma Treatment
    Busra Aydin et al, 2022, Neuroendocrinology CrossRef
15. Therapeutic and Diagnostic Antibodies to CD146: Thirty Years of Research on Its Potential for Detection and Treatment of Tumors
    Jimmy Stalin et al, 2017, Antibodies CrossRef
16. Programmed cell death, redox imbalance, and cancer therapeutics
    Xiaofeng Dai et al, 2021, Apoptosis CrossRef